| Name | Title | Contact Details |
|---|
For over 33 years, AultCare has been an industry leader in a competitive health care market. Through innovative plan designs, superior customer service and a cost effective, high quality network, AultCare has continued to keep enrollees and clients satisfied while remaining committed to providing affordable health care options. Throughout the years, AultCare has grown to become a valuable asset to our community. AultCare keeps costs lower than other areas in Ohio through our effective, high quality network. Our margins are smaller than national plans because we have accountability to our local community of individuals and employers. During our 30 years as an organization, teamwork has been a steadfast theme and it continues to remain an integral principle in our culture of nearly 500 employees. The unity of our teamwork has allowed us to be at the forefront for offering efficient health care to our community. Additionally, our commitment to teamwork has helped us provide excellent customer service, quality, and cost effective health care planning, which is at the standard core of our philosophy. Superior customer service is also an integral part of our daily business interactions. Due to the complexity of the health care industry, questions from members and employers may arise. All of our employees strive to provide an extra, personalized touch through all member interactions, whether over the phone or in person. AultCare brings a value to health care that is unparalleled in the market. As we continue to evolve, AultCare will welcome your feedback, strive to maintain our position as a steadfast leader in the health care industry, and be proud to serve you.
Strategic Healthcare Programs is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
We believe affordable, convenient vision prescriptions are a good thing. We started Opternative to provide a safe, online option for vision testing. It`s a way to get prescriptions between eye exams. Eyes stay healthy. People can see clearly. It`s a win-win.
MacConnell Research Corp. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.